| 专利名称 | Use of ureidomustine (BO-1055) in cancer treatment | ||
| 申请号 | US15745639 | 申请日 | |
| 公开（公告）号 | US10548861B2 | 公开（公告）日 | |
| 申请（专利权）人 | Academia Sinica; Memorial Sloan Kettering Cancer Center | 发明人 | Malcolm Moore; Jae Hung Shieh; Tsann Long Su; Te Chang Lee |
| 专利来源 | 国家知识产权局 | 转化方式 | |
| 摘要 |
Method of using ureidomustine (BO-1055), a water-soluble NDA cross-linking agent, in the treatment of a cancer, selected from the group consisting of various types of human leukemia [such as acute myeloid leukemia (ALL) and acute B Lymphoblastic leukemia (B-ALL)], lymphomas, small lung cell carcinoma (SCLC), sarcomas, and others. |
||
主管部门：海南中小企业服务 | 建设单位：海南商业联合会
版权所有：海南商业联合会 | 备案号：粤ICP备13083911号（ICP加挂服务）@2017
